BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Cun-Li Guo, Hai-Chao Yang, Xiu-Hua Yang, Wen Cheng, Tian-Xiu Dong, Wen-Jing Zhu, Zheng Xu, Liang Zhao. Associations Between Infiltrating Lymphocyte Subsets and Hepatocellular CarcinomaAsian Pacific Journal of Cancer Prevention 2012; 13(11): 5909 doi: 10.7314/APJCP.2012.13.11.5909
2
Emilien Loeuillard, Caitlin B. Conboy, Gregory J. Gores, Sumera Rizvi. Immunobiology of cholangiocarcinomaJHEP Reports 2019; 1(4): 297 doi: 10.1016/j.jhepr.2019.06.003
3
Swetha Kambhampati, Kelly E. Bauer, Paige M. Bracci, Bridget P. Keenan, Spencer C. Behr, John D. Gordan, Robin K. Kelley. Nivolumab in patients with advanced hepatocellular carcinoma and Child‐Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case seriesCancer 2019; 125(18): 3234 doi: 10.1002/cncr.32206
4
Takayuki Takeichi, Paulius Mocevicius, Olegas Deduchovas, Olga Salnikova, Edward Castro-Santa, Markus W. Büchler, Jan Schmidt, Eduard Ryschich. αLβ2 Integrin is indispensable for CD8+ T-cell recruitment in experimental pancreatic and hepatocellular cancerInternational Journal of Cancer 2012; 130(9): 2067 doi: 10.1002/ijc.26223
5
Xianwen Ren, Zemin Zhang. Advances in Immunology in China - Part AAdvances in Immunology 2019; 144: 217 doi: 10.1016/bs.ai.2019.08.004
6
Ines Malenica, Matteo Donadon, Ana Lleo. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized MedicineCancers 2020; 12(8): 2190 doi: 10.3390/cancers12082190
7
Olga Salnikova, Kai Breuhahn, Natalie Hartmann, Jan Schmidt, Eduard Ryschich. Endothelial plasticity governs the site-specific leukocyte recruitment in hepatocellular cancerInternational Journal of Cancer 2013; 133(10): 2372 doi: 10.1002/ijc.28268
8
Qing Pang, Lei Zhou, Kai Qu, Rui-Xia Cui, Hao Jin, Hui-Chun Liu. Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology 2018; 30(1): 60 doi: 10.1097/MEG.0000000000001021
9
Luca Vigano, Cristiana Soldani, Barbara Franceschini, Matteo Cimino, Ana Lleo, Matteo Donadon, Massimo Roncalli, Alessio Aghemo, Luca Di Tommaso, Guido Torzilli. Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete SurgeryJournal of Gastrointestinal Surgery 2019; 23(11): 2216 doi: 10.1007/s11605-019-04111-5
10
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic ImplicationsInternational Journal of Molecular Sciences 2019; 20(17): 4154 doi: 10.3390/ijms20174154
11
Atsushi Kawabata, Naomi Ohta, Garret Seiler, Marla M. Pyle, Susumu Ishiguro, Yong Qing Zhang, Kevin G. Becker, Deryl Troyer, Masaaki Tamura. Naïve rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responsesCytotherapy 2013; 15(5): 586 doi: 10.1016/j.jcyt.2013.01.006
12
Alessandra Caligiuri, Mirella Pastore, Giulia Lori, Chiara Raggi, Giovanni Di Maira, Fabio Marra, Alessandra Gentilini. Role of Chemokines in the Biology of CholangiocarcinomaCancers 2020; 12(8): 2215 doi: 10.3390/cancers12082215
13
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera Rizvi, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and managementNature Reviews Gastroenterology & Hepatology 2020; 17(9): 557 doi: 10.1038/s41575-020-0310-z
14
Tiantian Liu, Hao Wu, Jianni Qi, Chengyong Qin, Qiang Zhu. Seven immune‐related genes prognostic power and correlation with tumor‐infiltrating immune cells in hepatocellular carcinomaCancer Medicine 2020;  doi: 10.1002/cam4.3406
15
S. Ohfuji. Hepatocellular carcinoma in a cow: detection of tumor-infiltrating T lymphocytes implicated in anti-tumor immune response and partial spontaneous tumor regressionComparative Clinical Pathology 2016; 25(2): 421 doi: 10.1007/s00580-015-2202-0
16
Kuo-Shyang Jeng, Chiung-Fang Chang, Wen-Juei Jeng, I-Shyan Sheen, Chi-Juei Jeng. Heterogeneity of hepatocellular carcinoma contributes to cancer progressionCritical Reviews in Oncology/Hematology 2015; 94(3): 337 doi: 10.1016/j.critrevonc.2015.01.009
17
Tingting Fang, Li Feng, Jinglin Xia. Application of Clinical BioinformaticsTranslational Bioinformatics 2016; 11: 371 doi: 10.1007/978-94-017-7543-4_16
18
Amedeo Sciarra, Inês Monteiro, Christine Ménétrier-Caux, Christophe Caux, Benoit Gilbert, Nermin Halkic, Stefano La Rosa, Pedro Romero, Christine Sempoux, Laurence de Leval. CD73 expression in normal and pathological human hepatobiliopancreatic tissuesCancer Immunology, Immunotherapy 2019; 68(3): 467 doi: 10.1007/s00262-018-2290-1
19
Evgeny V. Denisov, Tatiana S. Gerashchenko, Marina V. Zavyalova, Vasiliy N. Manskikh, Evgeny L. Choinzonov, Nadezhda V. Cherdyntseva, Vladimir M. Perelmuter. Hepatocellular Carcinoma2016; : 211 doi: 10.1007/978-3-319-34214-6_14
20
Luca Fabris, María J. Perugorria, Joachim Mertens, Niklas K. Björkström, Thorsten Cramer, Ana Lleo, Antonio Solinas, Hanna Sänger, Veronika Lukacs‐Kornek, Anja Moncsek, Alexander Siebenhüner, Mario Strazzabosco. The tumour microenvironment and immune milieu of cholangiocarcinomaLiver International 2019; 39(S1): 63 doi: 10.1111/liv.14098
21
Chunhong Zheng, Liangtao Zheng, Jae-Kwang Yoo, Huahu Guo, Yuanyuan Zhang, Xinyi Guo, Boxi Kang, Ruozhen Hu, Julie Y. Huang, Qiming Zhang, Zhouzerui Liu, Minghui Dong, Xueda Hu, Wenjun Ouyang, Jirun Peng, Zemin Zhang. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell SequencingCell 2017; 169(7): 1342 doi: 10.1016/j.cell.2017.05.035
22
Lorenza Rimassa, Nicola Personeni, Alessio Aghemo, Ana Lleo. The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicineJournal of Autoimmunity 2019; 100: 17 doi: 10.1016/j.jaut.2019.03.007
23
Hang Yuan, Jiaxi Mao, Cong Liu, Hong Fu, Wenyuan Guo, Guoshan Ding. Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2020;  doi: 10.1016/j.clinre.2020.02.012
24
Chunye Zhang, Ming Yang, Aaron C. Ericsson. Antimicrobial Peptides: Potential Application in Liver CancerFrontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01257
25
Bridget P. Keenan, Lawrence Fong, Robin K. Kelley. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune responseJournal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0749-z
26
Yan Shao, Chung Mau Lo, Chang Chun Ling, Xiao Bing Liu, Kevin Tak-Pan Ng, Andrew Chi Yuen Chu, Yuen Yuen Ma, Chang Xian Li, Sheung Tat Fan, Kwan Man. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathwayCancer Letters 2014; 355(2): 264 doi: 10.1016/j.canlet.2014.09.026
27
Nicholas J. W. Easom, Michael Marks, Dawda Jobe, Roopinder Gillmore, Tim Meyer, Mala K. Maini, Ramou Njie. ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts OutcomeFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00971
28
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, Andrew X. Zhu. Systemic therapies for intrahepatic cholangiocarcinomaJournal of Hepatology 2020; 72(2): 353 doi: 10.1016/j.jhep.2019.10.009